Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Kaposi × Lopinavir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma, Kaposi 1 Respiratory Distress Syndrome 1 Prostatic Neoplasms 1 Pneumonia, Viral 1 Oligodendroglioma 1 Melanoma 1 Hodgkin Disease 1 High-Grade Anal Intraepithelial Neoplasia 1 Hematologic Neoplasms 1 HIV Infections 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Ependymoma 1 Cytokine Release Syndrome 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Astrocytoma 1 Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 10 Zidovudine 7 Vincristine 7 Bleomycin 7 Nivolumab 5 Liposomes 5 Interferon alpha-2 5 pembrolizumab 4 liposomal doxorubicin 4 Semaxinib 4 Paclitaxel 4 Nelfinavir 4 Etoposide 4 tecogalan 3 pomalidomide 3 Specimen Handling 3 Ritonavir 3 Magnetic Resonance Spectroscopy 3 Filgrastim 3 Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 sargramostim 2 interferon alfa-n1 2 Valganciclovir 2 Propranolol 2 Indinavir 2 Docetaxel 2 Didanosine 2 Daunorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00444379 2014-08-20

ARKS

University of California, San Francisco

Phase 4 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡